NYSE:JNJ 12 February 2026

Johnson & Johnson stock price nudges higher after BofA target hike; investors eye April 14 update

Johnson & Johnson stock price nudges higher after BofA target hike; investors eye April 14 update

Johnson & Johnson shares closed up 0.05% at $248.56 in after-hours trading Monday after Bank of America raised its price target to $253. The company scheduled a first-quarter results call for April 14 at 8:30 a.m. ET. Shares traded between $246.87 and $251.71 during the session, with volume near 8.7 million. J&J remains involved in ongoing talc litigation.
March 3, 2026
AbbVie stock jumps as Botox Medicare lawsuit puts Washington back in focus

AbbVie stock jumps as Botox Medicare lawsuit puts Washington back in focus

AbbVie shares rose nearly 3% after the company sued U.S. health agencies to block Medicare price controls for Botox. The lawsuit argues Botox should be exempt from the Inflation Reduction Act’s negotiation program as a plasma-derived product. Investors are watching for early court developments and the Medicare timeline for 2028 prices. The case was assigned to U.S. District Judge Carl Nichols.
February 12, 2026